CordenPharma inks deal to develop pHLIP LNP platform - BioProcess International

Retrieved on: 2024-01-17 12:31:15

Tags for this article:

Lipids

Solid lipid nanoparticle

Biotechnology

Intracellular delivery

Contract manufacturing organization

LNP

Peptide

Click the tags to see associated articles and topics

CordenPharma inks deal to develop pHLIP LNP platform - BioProcess International. View article details on HISWAI: https://bioprocessintl.com/bioprocess-insider/deal-making/cordenpharma-inks-deal-to-develop-phlip-lnp-platform/

Summary

CordenPharma partners with pHLIP to enhance biotechnology by developing lipid nanoparticle (LNP) platforms for mRNA and gene therapy, harnessing lipid and peptide technology for targeted intracellular delivery, supported by a contract manufacturing organization (CMO).

Article found on: bioprocessintl.com

View Original Article